EXECUTIVE COMMITTEE

Dr. Gianni Zampieri

Dr. Gianni Zampieri

CEO Vifor Pharma

Dr. Gianni Zampieri

Dr. Gianni Zampieri

CEO Vifor Pharma

  • Swiss citizen
  • PhD ETH Zurich (Federal Institute of Technology), postgraduate study economics, Senior Executive Program, Stanford University, USA
  • Held positions with Hofmann-La Roche and Novartis (Strategic Planning)
  • Joined the company in 1996 as CEO Vifor (International) Ltd., then became Head of the Pharma Division, Galenica Group; since 2002 Member of the Corporate Executive Committee, 2008 Head of Industrial Operations Vifor Pharma and in 2010 CEO of OM Pharma,2011 Deputy CEO of Vifor Pharma, 2012 - 2016 Deputy CEO & Head of Pharma Operations
  • Since October 2016 CEO

Beatrix Benz

Beatrix Benz

Head of Global Communications & Public Affairs*

Beatrix Benz

Beatrix Benz

Head of Global Communications & Public Affairs*

  • Swiss citizen
  • Bachelor of Arts, Communications and Journalism, Institute for Applied Media Science, University of Applied Science, Zurich
  • Leading positions such as Head of Communications Europe & Asia-Pacific with Novartis Animal Health, Director Global Media Relations and Global Spokesperson with Novartis International AG and Associate Director External Communications and Global Spokesperson with Nycomed International
  • Joined the company as Head of Global Communications in 2011
  • As of 2015, Head of Global Communications & Public Affairs
Colin Bond

Colin Bond

Chief Financial Officer

Colin Bond

Colin Bond

Chief Financial Officer

  • British and Swiss citizen
  • FCA, Institute of Chartered Accountants in England and Wales, MRPharmS, Royal Pharmaceutical Society of Great Britain, MBA, London Business School, BSc. in Pharmacy, University of Aston in Birmingham
  • Leading positions such as CFO of the listed biotechnology company Evotec, CFO of Jet Aviation Group, CFO (EMEA) for Ecolab and CFO of Novelis Europe . During his early career he worked as a pharmacist, auditor and management consultant for Procter & Gamble, Arthur Andersen and PricewaterhouseCoopers.
  • Since 2013 Board member, Chairman of the Audit Committee of Siegfried AG
  • Joined the company in 2016 as CFO





Dario Eklund

Dario Eklund

Head of Global Business Operations

Dario Eklund

Dario Eklund

Head of Global Business Operations

  • Finnish/Austrian citizen
  • Master in Science, Swedish School of Economics and Business Administration in Helsinki, Finland
  • Leading positions such as Commercial Director, Area Manager Eastern Europe & Israel and Country Manager with Novartis, Switzerland & USA, General Manager of Aventis Pharma AG (now Sanofi), Switzerland and Vice President for Non US Operations, Business Development and Gintuit Business Unit with Organogenesis Inc., USA
  • Joined the company as Head of Global Business Operations in 2014
Dr. Behruz S. Eslami

Dr. Behruz S. Eslami

Global Head of Regulatory Affairs*

Dr. Behruz S. Eslami

Dr. Behruz S. Eslami

Global Head of Regulatory Affairs*

  • American citizen
  • PhD in Molecular Biology, New York Medical College, New York, USA, Bachelor of Science in Chemistry, Southern Connecticut State University, New Haven, USA
  • Leading positions such as Regulatory Affairs Director with ARES-SERONO International, Geneva, Switzerland, Group Vice President Regulatory Affairs Europe, with Genzyme Europe, Naarden, The Netherlands
  • Joined the company as Global Head of Regulatory Affairs Vifor Pharma in 2010

Dr. Thomas Kaspar

Dr. Thomas Kaspar

Global Head Quality Management*

Dr. Thomas Kaspar

Dr. Thomas Kaspar

Global Head Quality Management*

  • Swiss citizen
  • Dr. Sc. Nat. ETHZ; Diploma in Economics at the Fachhochschule Nordwestschweiz
  • Worked at Streuli Pharma AG in the position of Head Quality Control Microbiology from 1996 - 2000
  • Joined the company in 2000 and worked in different positions
  • Since 2011 Global Head Quality Management
Dr. Oliver P. Kronenberg

Dr. Oliver P. Kronenberg

Group General Counsel

Dr. Oliver P. Kronenberg

Dr. Oliver P. Kronenberg

Group General Counsel

      • Swiss citizen
      • PhD in Law at the University of Basel; College of Europe, Bruges (Belgium), LL.M.; Fordham School of Law, New York (USA), Visiting Scholar; Admitted to the Swiss Bar
      • Associate at Sutter Attorneys-at-law in Zurich and Legal Counsel at ISL Worldwide in Zug. 2001 - 2004 he held several positions at the Fédération International de Football Association (FIFA) in Zurich, most recently as Head of General Legal. Corporate Counsel in Copenhagen at Ferring Pharmaceutical A/S. Returned to Zurich as Head of Legal at Kuros Biosurgery AG
      • Joined the company in 2008 as Head of Legal & Compliance, appointed to Chief of Staff and General Counsel Vifor Pharma in 2011
      • Since 2014 Group General Counsel



    Dr. Abdul Mullick

    Dr. Abdul Mullick

    Head Global Marketing

    Dr. Abdul Mullick

    Dr. Abdul Mullick

    Head Global Marketing

    • British citizen
    • Ph.D. in Molecular Biology, Bristol University, UK
    • Leading positions such as Senior Global Brand Director, Diabetes with Novartis Pharma AG, Switzerland. European Business Unit Senior Director, Endocrine, Vice President & Head of Global Marketing, Rare Genetic Diseases and Vice President & General Manager, Endocrinology and Cardiology with Genzyme Corporation (now Sanofi), Cambridge, MA, USA
    • Joined the company as Head of Global Marketing in 2014
    Michael Puri

    Michael Puri

    Head Global Human Resources

    Michael Puri

    Michael Puri

    Head Global Human Resources

    • Belgium citizenof Indian and Polish origins
    • Bilingual in English and French and conversational in Italian and Dutch
    • Bachelor (Hons.) in Economics & Master in Strategic Marketing, University of Nantes and ESG Management School of Grenoble, France
    • Started his professional life in Marketing but then moved to HR where he has since developed a multinational career over the last 15 years, working amongst others as Senior Director Global Talent Development for UCB and Vice President Human Resources Europe for Staples
    • Joined us from GrandVision where he served as the Global Head of the HR function and a member of the Global Executive Team
    • Since 2015 Senior Vice President & Head Global Human Resources Vifor Pharma

    Dr. Dirk Schrader

    Dr. Dirk Schrader

    Head of Technical Operations

    Dr. Dirk Schrader

    Dr. Dirk Schrader

    Head of Technical Operations

    • German citizen
    • PhD in Pharmaceutical Technology, WWU Muenster, Germany, Pharmaceutical Approbation, Technical University Braunschweig, Germany
    • Worked from 1992-2005 in various technical and commercial positions at Bayer, as head of a production unit in Germany, Head of Technical Operations in China, Senior Vice President International Technical Operations, General Manager for the Healthcare Businesses in Taiwan and as Head of the Diagnostics/Diabetes Care business based in Switzerland
    • Then moved to Singapore as VP Operations & Supply Asia Pacific/Japan for Bristol-Myers Squibb and in 2007 changed to AstraZeneca, first as VP Supply Asia Pacific/Japan in Singapore and from 2010 as VP Lean Operations in the UK
    • Joined the company as Head of Industrial Operations in 2012
    • Head of Technical Operations since June 2016
    Stefan Schulze

    Stefan Schulze

    Designated Chief Operating Officer (COO) as of the 2017 Annual General Meeting of Galenica Ltd. and CEO Vifor Fresenius Medical Care Renal Pharma Ltd., Member of the Vifor Pharma Executive Committee

    Stefan Schulze

    Stefan Schulze

    Designated Chief Operating Officer (COO) as of the 2017 Annual General Meeting of Galenica Ltd. and CEO Vifor Fresenius Medical Care Renal Pharma Ltd., Member of the Vifor Pharma Executive Committee

    • German citizen
    • Industrial Engineer, Technical University of Berlin, Germany
    • Leading positions such as Executive Vice President Sales & Marketing Fresenius AG, Germany, President and General Manager of Fresenius HemoCare’s Adsorber Technology Business Unit, Germany, President Fresenius HemoCare, USA and Senior Vice President Business Development Fresenius Medical Care North America, Germany & USA
    • Joined the company as CEO Vifor Fresenius Medical Care Renal Pharma Ltd.; member of the Vifor Pharma Executive Committee in 2014

    Alex Sigalas

    Alex Sigalas

    Head of Finance & Admin*

    Alex Sigalas

    Alex Sigalas

    Head of Finance & Admin*

    • Swiss citizen
    • Lic. oec. HSG, specialty finance and cost accounting, University of St. Gallen; Swiss CPA External Auditor with PricewaterhouseCoopers, Controller with Accenture & Société Générale Private Banking, Internal Audit Manager with Actelion & Syngenta, Finance Director Headquarters with Actelion
    • Joined the company in 2009 as CFO (Finance, IT & Admin)
    • Since 2016 Head of Finance & Admin
    Dr. Christoph Springer

    Dr. Christoph Springer

    Head of Global Business Development of Vifor Pharma, Vice-CEO Vifor Fresenius Medical Care Renal Pharma Ltd.

    Dr. Christoph Springer

    Dr. Christoph Springer

    Head of Global Business Development of Vifor Pharma, Vice-CEO Vifor Fresenius Medical Care Renal Pharma Ltd.

    • Swiss citizen
    • Master of Natural Science at the Swiss Federal Institute of Technology (ETH) Zurich, PhD in Molecular Biology at Georg-August-University, Göttingen, MBA studies at George Washington University, Washington DC
    • Global Product Leader Anaemia, with Vifor (International) Ltd., then General Manager and International Marketing Director Anaemia with AMGEN Switzerland AG
    • Joined the company in 2007 as Global Head of Anaemia TA Marketing
    • Since 2011 Deputy CEO Vifor Fresenius Medical Care Renal Pharma Ltd.
    • Since 2016 Head of Global Business Development of Vifor Pharma

    Thierry Teil

    Thierry Teil

    Global Head Medical Affairs*

    Thierry Teil

    Thierry Teil

    Global Head Medical Affairs*

    • US and French citizen
    • M.D., University of Lyon Claude Bernard, Lyon, France, MBA, IGS (Institute de Gestion Sociale), IMIS (Institute of Management for Health Industries), Paris, France
    • Leading positions such as Head of Global Medical Affairs, NPS Pharma, Managing Director Russia-CIS of UCB, Head of Global Medical Affairs of UCB Belgium, Head of Alliance Management of The Medicines Company
    • Joined the company in 2016 as Head Global Medical Affairs
    Stefan Wohlfeil

    Stefan Wohlfeil

    Chief Medical Officer & Head of R&D

    Stefan Wohlfeil

    Stefan Wohlfeil

    Chief Medical Officer & Head of R&D

    • German citizen
    • Medical School Düsseldorf, Germany
    • Held various positions with Bayer AG, Founder and CEO of Atani Limited London and Atani KK, Tokyo, CEO of TRIN Pharma, Switzerland, Head Clinical Pharmacology and Clinical Research with Novartis Consumer Health OTC
    • Joined the company as Head of Chemical and Preclinical Research and Development for OM Pharma and Vifor Pharma in 2012
    • Chief Medical Officer & Head of R&D since 2013


    Send link

    Send as link



    Links